<DOC>
	<DOCNO>NCT01195727</DOCNO>
	<brief_summary>CV185-079 multiple dose Apixaban Pharmacokinetics/Pharmacodynamics ( PK/PD ) study pediatric subject . The objective study primarily study PK/PD Apixaban pediatric subject central venous catheter .</brief_summary>
	<brief_title>Multiple-Dose Study Apixaban Pediatric Subjects With Indwelling Central Venous Catheter</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<criteria>Subjects chronic stable disease type function CVC upper lower venous system ( e.g. , jugular , subclavian ; femoral vein ) anticipate remain subject treatment portion study . &gt; 12 &lt; 18 year age Current recent ( within 3 month study drug administration ) gastrointestinal disease gastrointestinal surgery , opinion investigator BMS Medical Monitor , could impact absorption study drug Active bleeding high risk bleeding</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>